NANCY WILCOX: Open Payments
NPI 1003356668 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 51 payments from 14 companies in 2025. Trend: 2023 $432 · 2024 $1,051 · 2025 $1,411
Food & beverage: $1,208Education: $203
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 20 | $489 |
| Janssen Biotech, Inc. | 6 | $204 |
| Astellas Pharma US Inc | 7 | $180 |
| Olympus America Inc. | 1 | $146 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| COLOPLAST CORP | 3 | $69 |
| TOLMAR, INC. | 2 | $46 |
| Antares Pharma, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| ABBVIE INC. | 2 | $32 |
Products named: GEMTESA, ERLEADA, iTIND System, Xtandi, SpeediCath, ORGOVYX, KEYTRUDA, XYOSTED.
Industry payments across NY — which companies pay providers there.
